L'Oreal lifts stake in Swiss dermatology group Galderma to 20%

8th Dec 2025 12:37

(Sharecast News) - Swiss dermatology company Galderma Group said on Monday that L'Oreal plans to buy an additional 10% stake from a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment.

The deal, which is expected to close in the first quarter of next year, will take L'Oreal's stake to 20%.

In connection with the increased investment, Galderma said it will consider nominating two non-independent board candidates from L'Oreal at the 2026 annual general meeting, replacing the board members which represented the consortium.

In addition, Galderma and L'Oreal "aim at exploring additional scientific research projects of mutual interest," it said.

Galderma chief executive Flemming Ørnskov said: "Galderma continues to deliver impressive growth, strong innovation and category leadership across its broad, science-based dermatology portfolio. With strengthened commercial execution, continued platform and portfolio expansion, and an increasingly consumer-focused approach to innovation, we are rapidly scaling into a dermatology powerhouse.

"We are pleased with L'Oreal's increased investment, which affirms our direction and the meaningful value creation we expect in the years ahead. As we move into 2026, we remain fully focused on our Integrated Dermatology Strategy and on serving our customers, consumers, and patients."

At 1230 GMT, Galderma shares were up 2.5% at CHF166.90, while L'Oreal was down 2% at €365.15.